United States:
FDA Reopens Docket For Comments On GDUFA
18 February 2015
Jones Day
To print this article, all you need is to be registered or login on Mondaq.com.
In the February 6, 2015, Federal Register,
FDA reopened the docket to solicit public comment on certain topics
related to implementation of the Generic Drug User Fee Amendments
of 2012 ("GDUFA") and the GDUFA Commitment Letter that
accompanies the legislation. Comments due March 9,
2015.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
Manatt Health: Health AI Policy Tracker
Manatt, Phelps & Phillips LLP
The purpose of this quarterly tracker is to identify key federal and state health AI policy activity. Below reflects federal legislative and regulatory activity to date related to AI...